Firstly, welcome Rishi, whatever you and I think of his politics and experience, as an Anglo-Indian growing up in Cambridge in the 70’s and 80s, it is unbelievable that today we have an Anglo-Indian Prime Minister in the United Kingdom. His presence seems to be bringing calm to the markets. It is safe to assume that we are in a period of higher taxes to balance the books that we were under the leadership of Liz Truss.
Knowledge Intensive Fund Fully Invested
We have planned investments that will close in the 2-4 few weeks into:
Kuano: Kuano is an artificial intelligence company using quantum computing to create molecular design solutions.
Qkine : Qkine manufactures high quality growth factors and cytokines for stem cell, organized and regenerative medicine applications.
PharmEnable : PharmEnable supports early drug discovery programs by providing a rapid, cost efficient, and effective platform to identify new hit candidates.
These investments will close to fully invest all our Knowledge Intensive Funds and thus we are seeking to raise a new fund which will close on November 15th 2023.
EIS Certificate Updates
We are pleased to share that, since we have already invested more than 90% of the funds from the o2h human health KI Fund that closed on April 5th, April 2021, and October 30th, 2021, we will be issuing EIS5 Certificates to our investors in the coming days. You will be able to download this from our portal at https://www.o2hventures.com We will send you an email as soon as we have received and uploaded this.
New Investments for 2022/23
We are now working on due diligencing new investments and already in the pipeline we have pre-emption rights into companies such as Somaserve, Phoremost, Exonate, Alevin and Stingray which are strong candidates for further investment.
Latest News from October
We attended Ready Steady Grow events organized by the Enterprise Investment Scheme Association (EISA) in Bristol, Manchester, and Belfast. Being on the panel and having the opportunity to interact, converse, and exchange knowledge about EIS and SEIS with other professionals in the field was amazing and a wonderful experience.
KI Fund Close on November 15th 2022
Our HMRC approved the o2h human health knowledge-intensive EIS fund IV, is open for investment and the next close is coming up in 2 weeks time. The key benefits of investing in knowledge-intensive EIS funds are:
– Carry Back EIS Tax Relief: Carry back EIS tax relief to 2021/22, or the benefit of investing in this current year.
– Tax Relief: Can claim tax relief up to £2m per annum, provided that £1m is invested in the knowledge intensive companies.
– Simplified Paperwork: A single EIS5 Certificate for your investment rather than the typical 10–15 separate EIS3 certificates.
The fund aims to invest in early stage biotech companies that are involved in research, development, or innovation activities.
Our onboarding procedure is quite quick—it won’t even take more than five to ten minutes.
In case you run into trouble or want to learn more about the funds, we can set up a call and provide you with additional details. Just send us a short note to invest@o2h.com, and we’ll set up a time.
